top of page

ASAP Treatment Networking Group

Public·69 members

Anna Unnerstall
Anna Unnerstall

April 17, 2026

Quick recap


The meeting focused on challenges facing behavioral health providers, particularly regarding increased scrutiny from HHSC and funding issues. Providers discussed experiencing more detailed audits and questions about their match reports and in-kind donations, with several organizations reporting difficulties with quarterly reporting processes. The group extensively discussed the decline in residential treatment services, citing low payment rates compared to outpatient services and the closure of detox programs as contributing factors. Providers shared experiences with Medicaid billing challenges, including low payment rates and denial issues, with some organizations achieving only 57% collection rates on billed amounts. The conversation also covered the impact of buprenorphine prescriptions being provided in emergency rooms, which has reduced referrals to residential treatment programs. The conversation ended with a discussion about implementing a new online platform for member communication and feedback collection regarding service gaps and challenges.


Next steps


13 Views
ddenton
Apr 17

Over the years, our auditors make sure that we follow federal regulations as published in the Uniform Grant Guidelines. We are very careful to document as follows:


Donated goods and materials fall under the Uniform Guidance’s treatment of “in‑kind contributions” and are primarily addressed in:


2 CFR § 200.306 – Cost Sharing or Matching

2 CFR § 200.434 – Contributions and Donations


Under the Uniform Guidance, donated goods and materials (for example, supplies... provided at no charge) are treated as third‑party in‑kind contributions.


Donated goods and materials can be counted only if all cost‑sharing conditions are met under 2 CFR § 200.306(b). Specifically, the contribution must:

Be verifiable in the recipient’s records

Not be counted toward another federal award

Be necessary and reasonable for accomplishing the project objectives

Be allowable under the cost principles in Subpart E

Not be paid by the federal government under another award

Be included in the approved budget when required

Conform to all other applicable provisions of Part 200

Donated goods and materials must be valued at their fair market value at the time of donation—that is, what a willing buyer would pay a willing seller in an arms‑length transaction. The recipient must use the same valuation methods it uses for its own purchased goods, ensuring consistency and auditability. [govinfo.gov]

Anna Unnerstall
Anna Unnerstall

Inform the Statewide Coordinating Council

We are gathering input to inform recommendations to the Statewide Behavioral Health Coordinating Council. Your feedback is critical to ensuring provider perspectives are reflected. Please share your thoughts below.


Current System Gaps and Challenges

  • What are the most significant service gaps today in the mental health and substance use treatment system in Texas?

  • Which populations or regions are most impacted by these gaps, and why?

  • Where do you see the most significant breakdowns in the statewide continuum of care?

  • What policy or funding barriers most hinder statewide mental health and substance use treatment service delivery?


20 Views
koverman
Apr 17

Current System Gaps and Challenges

  • What are the most significant service gaps today in the mental health and substance use treatment system in Texas? SDOH supports required to adequately address treatment needs. Patient access to a full continuum of care. Adequate funding for treatment of indigent populations. Gulf between MH and SUD, despite SUD being a MH diagnosis.

  • Which populations or regions are most impacted by these gaps, and why? Indigent populations (funding for treatment and availability of services), pregnant women, mothers (need for specialized care and childcare), Spanish speaking and other marginalized groups (access to ESL care, access to culturally competent care)

  • Where do you see the most significant breakdowns in the statewide continuum of care? Piecemeal approach to services and outcomes measures that only increase the piecemeal nature of funding. Wildly complex braid of funding sources required to keep a facility in operation. Heavy administrative burden with no capacity building funding.

  • What policy or funding barriers most hinder statewide mental health and substance use treatment service delivery? Structure of fee-for-service grants, piecemeal and conflicting funding opportunities, loss of direct service funding to administrative bloat with “trickle down” award structures, lack of clarity on the role of LMHAs for specialty services, outdated and burdensome nature of CMBHS

  • What do you believe are the fundamental causes of these challenges? Failure/Unwillingness to understand at the state level that failure to treat Texans’ behavioral health issues costs taxpayers exponentially in terms of law enforcement, hospital, jail, DFPS, etc. costs. Poor understanding of SUD and other behavioral health issues (you can fix a broken leg and then the leg is fixed, but you can’t “fix” heart disease anymore than you can “fix” lifelong behavioral health disorders, treatment and long-term social supports are required) Poor understanding of the landscape on behalf of HHS, extremely outdated and inefficient systems for both assessing the needs and tracking progress on awards, clunky fee-for-service processes.

 


 

Solutions and Innovations

  • What models, programs, or innovations have you seen meaningfully improve access, outcomes, or efficiency? Cost-reimbursement grants requiring meaningful outcomes measures. Modernizing data infrastructure AND allowing providers to submit data outcomes from their own data systems without requiring duplicative state managed systems.  Prioritizing funding care providers with proven models, balancing that with funding novel models. Prioritizing funding a full continuum of care over piecemeal elements. Funding capacity expansion, or models that allow providers to consolidate common functions like training.

  • What solutions do you recommend Texas consider adopting or scaling? All of the above.

  • What funding or funding incentive structures are needed to support implementation or expansion? Capacity expansion, cost-reimbursement grants instead of fee-for-service.

 

Supporting Documentation and Additional Insights

  • What data, examples, or evidence can you share to support your recommendations? Staff cost for administration of CMBHS, HHS authorization and  billing. Texas CAC model for funding.

  • What have we not asked that you believe is important for the statewide behavioral health strategic plan and its implementation? 

 

Implementation Considerations

  • What barriers might Texas face in implementing these reforms? How might they be mitigated? Inertia, stigma about substance use, concern about fraud if there’s not today’s extremely detailed service billing process, and a lack understanding of failing to treat as a significant waste of taxpayer resources on law enforcement response, hospitals, jails and prisons, and DFPS. Lack of understanding regarding the additional administrative costs of layering funding through multiple administrative agencies. Ensuring that this knowledge is un-ignorable may help.

Anna Unnerstall
Anna Unnerstall

March 20, 2026

Meeting summary


Quick recap

This meeting focused on updates and discussions regarding substance use disorder treatment services and HHSC (Health and Human Services Commission) interactions. Noelle led the meeting in Doug's absence and provided updates on HHSC meetings, including discussions about OSARs contracts and the potential impact of GLP-1 medications on treatment approaches. The group discussed concerns about Medicaid rate increases, with Carrie sharing information about higher VA rates for residential treatment compared to current Medicaid rates. Participants also addressed issues with managed care organizations, procurement processes, and the disconnect between regulatory requirements and program implementation. The conversation ended with updates about upcoming HHSC rate evaluation meetings and the importance of providing feedback during the current sunset review process.

Next steps


8 Views
Anna Unnerstall
Anna Unnerstall

GLP-1 Medications & Mental Health: What Providers Should Know

A recent overview from Osmind highlights emerging evidence on GLP-1 receptor agonists (e.g., Ozempic, Wegovy) and their potential relevance in psychiatry and behavioral health.

Key Takeaways:

  • Reduced substance use & cravings:Early studies suggest GLP-1 medications may reduce cravings for alcohol, nicotine, and possibly other substances—raising interest in their role for SUD treatment.

  • Mental health effects (mixed but promising):Some patients report improvements in mood and compulsive behaviors, though data is still limited and not yet conclusive.

  • Mechanism matters:These medications act on brain reward pathways (dopamine-related systems), which may explain effects on addiction and impulse control—not just appetite.

  • Caution + monitoring needed:There are also reports of potential psychiatric side effects (e.g., mood changes, suicidal ideation), so careful screening and monitoring are essential.


13 Views

Members

  • carmenharriscarmenharris
    carmenharris
  • cluckyclucky
    clucky
  • lkincaidlkincaid
    lkincaid
  • melaniegmelanieg
    melanieg
  • deirdre.brownedeirdre.browne
    deirdre.browne

Events

  • 20 Nov Fri | 'ASAP Treatment Networking Meeting'

  • 16 Oct Fri | 'ASAP Treatment Networking Meeting'

bottom of page